Cough syrup row: Sample testing at designated labs now must for exporters
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
maiden pharma
May 2023
April 2023
January 2023
December 2022
October 2022
WHO warns against contaminated cough syrup made by Punjab-based pharma co
Global health body says this syrup contains "unacceptable amounts of diethylene glycol and ethylene glycol as contaminants", which is considered toxic to humans
Amid Gambia row, Maiden Pharma’s HP plant cough syrups flagged ‘spurious’
CDSCO in its December 2022 alert says five cough syrup samples produced by Maiden at its Baddi plant are "not of standard quality".
The Gambian deadlock: India's drug authority rejects Gambia panel's claim of child deaths from Maiden Pharma drug
The Drugs Controller General of India (DCGI) has ruled out contamination possibilities in the four products Maiden Pharma supplied to Gambia.
Maiden Pharma row: After Haryana, other states swing into action
On October 6, the World Health Organisation issued a global alert against the cough syrups produced by Maiden Pharma, after 66 children died in The Gambia following the consumption of cough syrups.
Maiden Pharma row: Firm ordered to stop cough syrup production
Notices served to the Sonipat-based company after raids by central & Haryana drug depts found 12 violations at its premises.
Probe begins after WHO issues alert for Made in India cough syrup
Maiden Pharmaceutical holds manufacturing permission for these products for export only, the government says.
Haryana pharma firm tied to kids' deaths in The Gambia; WHO issues ‘global alert’
WHO warns three cough syrups and an oral solution manufactured by Haryana-based Maiden Pharma are “substandard”, "toxic" and can prove to be ‘fatal’.
